Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Johnson & Johnson (JNJ) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 304,862,848
  • Shares Outstanding, K 2,735,880
  • Annual Sales, $ 70,074 M
  • Annual Income, $ 15,409 M
  • 36-Month Beta 0.72
  • Price/Sales 4.35
  • Price/Book 4.21

Price Performance

See More
Period Period Low Period High Performance
1-Month
109.32 +1.53%
on 12/07/16
122.50 -9.40%
on 11/09/16
-6.06 (-5.18%)
since 11/08/16
3-Month
109.32 +1.53%
on 12/07/16
122.50 -9.40%
on 11/09/16
-8.48 (-7.10%)
since 09/08/16
52-Week
94.28 +17.72%
on 01/21/16
126.07 -11.96%
on 07/20/16
+8.57 (+8.37%)
since 12/08/15

Most Recent Stories

More News
3 Stocks That Propelled the Dow to a Fresh All-Time High

Analyzing the reasons behind these gains could help us in ascertaining whether they are sustainable.

Asian stocks advance ahead of ECB decision

SEOUL, South Korea (AP) — Asian shares rose on Thursday after an overnight surge on U.S. markets. Investors were focused the European Central Bank's meeting later in the day.

The Zacks Analyst Blog Highlights: Johnson & Johnson, Wells Fargo, Wal-Mart, Kimberly-Clark and NIKE

The Zacks Analyst Blog Highlights: Johnson & Johnson, Wells Fargo, Wal-Mart, Kimberly-Clark and NIKE

Top Research Reports for December 6, 2016

Top Research Reports for December 6, 2016

AbbVie (ABBV) Presents Impressive Imbruvica Data at ASH

AbbVie Inc. (ABBV) and partner Janssen, Johnson & Johnson's (JNJ) pharmaceuticals subsidiary, presented encouraging results on their cancer drug Imbruvica at the annual meeting of the American Society...

Lilly: Jardiance Label to Add Cardiovascular Indication

Eli Lilly & Company (LLY) recently announced that the FDA has approved the inclusion of cardiovascular (CV) risk reduction data from the EMPA-REG OUTCOME study on its type II diabetes drug Jardiance's...

Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Nxstage Medical

Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Nxstage Medical

MedTech Sails Through Macro Woes: Stocks in Focus

MedTech Sails Through Macro Woes: Stocks in Focus

Funding For Lawsuits Extends Pinnacle Hip Lawsuit Funding

Funding for Lawsuits (www.fundingforlawsuits.com), LLC, the nation's fastest growing pre settlement funding firm, announces today that they are extending their Pinnacle Hip Lawsuit Funding program to qualified...

Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Roche

Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Roche

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Support & Resistance

2nd Resistance Point 111.98
1st Resistance Point 111.48
Last Price 110.99
1st Support Level 110.21
2nd Support Level 109.44

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.